423012 is a clinical research site located in Charlottesville, Virginia, United States 22908.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
423012 has participated in 1 clinical trials.
Therapeutic areas: MAC Lung Disease, Treatment Refractory MAC Lung Disease.
Sponsors: AN2 Therapeutics, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Virginia · View every site in Charlottesville
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
423012 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
423012 has 1 clinical trials on record. Their work covers MAC Lung Disease, Treatment Refractory MAC Lung Disease.
423012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.